23 results
8-K
EX-99.1
klpdgm7c
4 Nov 21
Vaxart Provides Business Update and Reports Third Quarter 2021 Financial Results
4:06pm
8-K
g4pvbnrq1gc 1d
23 Aug 21
Vaxart Announces Highly Regarded Biotech Executive Julie M. Cherrington, Ph.D., Joins Board of Directors
4:23pm
8-K
EX-99.1
9rihzesv5r znz9mh
23 Aug 21
Vaxart Announces Highly Regarded Biotech Executive Julie M. Cherrington, Ph.D., Joins Board of Directors
4:23pm
8-K
EX-99.1
7vd7ub9ucre685v4cb
5 Aug 21
Vaxart Provides Business Update and Reports Second Quarter 2021 Financial Results
4:08pm
8-K/A
EX-99.1
s4za17mh
23 Jan 13
Consolidated Statements of Operations
12:00am
DEFA14A
sqhl u0ymviv
23 Aug 12
Additional proxy soliciting materials
12:00am
DEFM14A
v0ev0 jz0he2wev9ng
7 Aug 12
Proxy related to merger
12:00am
DEFA14A
7h59vj7m
24 Apr 12
Additional proxy soliciting materials
12:00am